346 related articles for article (PubMed ID: 15459606)
1. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker dosing in community-based treatment of heart failure.
Fowler MB; Lottes SR; Nelson JJ; Lukas MA; Gilbert EM; Greenberg B; Massie BM; Abraham WT; Franciosa JA;
Am Heart J; 2007 Jun; 153(6):1029-36. PubMed ID: 17540206
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
Massie BM; Nelson JJ; Lukas MA; Greenberg B; Fowler MB; Gilbert EM; Abraham WT; Lottes SR; Franciosa JA;
Am J Cardiol; 2007 May; 99(9):1263-8. PubMed ID: 17478155
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
[TBL] [Abstract][Full Text] [Related]
5. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
6. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
[TBL] [Abstract][Full Text] [Related]
7. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
Fowler MB
Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
[TBL] [Abstract][Full Text] [Related]
9. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
[TBL] [Abstract][Full Text] [Related]
12. Predictors of clinical outcomes in patients given carvedilol for heart failure.
Greenberg B; Lottes SR; Nelson JJ; Lukas MA; Fowler MB; Massie BM; Abraham WT; Gilbert EM; Franciosa JA;
Am J Cardiol; 2006 Dec; 98(11):1480-4. PubMed ID: 17126654
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
[TBL] [Abstract][Full Text] [Related]
16. The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications.
Gattis WA; O'Connor CM; Gheorghiade M
Rev Cardiovasc Med; 2002; 3 Suppl 3():S48-54. PubMed ID: 12447162
[TBL] [Abstract][Full Text] [Related]
17. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
Takeda Y; Fukutomi T; Suzuki S; Yamamoto K; Ogata M; Kondo H; Sugiura M; Shigeyama J; Itoh M
Am J Cardiol; 2004 Aug; 94(4):448-53. PubMed ID: 15325927
[TBL] [Abstract][Full Text] [Related]
18. Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure.
Pasternak B; Svanström H; Melbye M; Hviid A
JAMA Intern Med; 2014 Oct; 174(10):1597-604. PubMed ID: 25173681
[TBL] [Abstract][Full Text] [Related]
19. Heart failure in community practice: relationship to age and sex in a beta-blocker registry.
Franciosa JA; Nelson JJ; Lukas MA; Lottes SR; Massie BM; Fowler MB; Greenberg B; Gilbert EM; Abraham WT;
Congest Heart Fail; 2006; 12(6):317-23. PubMed ID: 17170585
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.
Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK
Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
